Fed. Circ. OKs Mixed Ruling For Lundbeck In Trintellix IP Case
By Adam Lidgett · December 7, 2023, 9:15 PM EST
The Federal Circuit has backed a decision that a slew of generic-drug makers don't infringe two of H. Lundbeck's patents on antidepressant drug Trintellix, while also affirming a decision that Lupin...
To view the full article, register now.